CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells-Reference-Cited by-同舟云学术

CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells

Published:2016-08-31 Issue:42 Volume:7 Page:68385-68396
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Barbutti Isabella¹,Xavier-Ferrucio Juliana M.¹,Machado-Neto João Agostinho¹,Ricon Lauremilia¹,Traina Fabiola²,Bohlander Stefan K.³,Saad Sara Teresinha Olalla¹,Archangelo Leticia Fröhlich¹⁴

Affiliation:

1. Hematology and Hemotherapy Center, State University of Campinas (UNICAMP), Carlos Chagas 480, Campinas-SP, Brazil

2. Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

3. Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand

4. Department of Cellular and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target;Drug Development Research;2023-08-11

2. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation;PeerJ;2023-07-17

3. A bioinformatics analysis of the clinicopathological and prognostic significance of FAM64A mRNA expression in gynecological cancers;Journal of Obstetrics and Gynaecology;2023-05-25

4. Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients;Frontiers in Immunology;2022-07-15

5. PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2022-06